ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Lyra Therapeutics Inc

Lyra Therapeutics Inc (LYRA)

0.28
0.02
(7.69%)
Closed September 15 4:00PM
0.272
-0.008
(-2.86%)
After Hours: 7:47PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.272
Bid
0.275
Ask
0.2799
Volume
848,664
0.2599 Day's Range 0.3079
0.2532 52 Week Range 9.98
Market Cap
Previous Close
0.26
Open
0.261
Last Trade Time
Financial Volume
$ 229,633
VWAP
0.270582
Average Volume (3m)
2,315,830
Shares Outstanding
65,456,735
Dividend Yield
-
PE Ratio
-0.29
Earnings Per Share (EPS)
-0.96
Revenue
1.56M
Net Profit
-62.68M

About Lyra Therapeutics Inc

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
-
Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was $0.26. Over the last year, Lyra Therapeutics shares have traded in a share price range of $ 0.2532 to $ 9.98.

Lyra Therapeutics currently has 65,456,735 shares outstanding. The market capitalization of Lyra Therapeutics is $17.02 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.29.

LYRA Latest News

Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

– Primary focus continues to be on upcoming results from ENLIGHTEN 1 Phase 3 extension study in 4Q 2024 and ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients in 1H 2025, as planned – – In...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.024-8.108108108110.2960.34260.25468503700.304204CS
40.01023.89610389610.26180.3440.253212876700.29104355CS
12-5.958-95.63402889256.236.790.253223158300.69928467CS
26-4.308-94.06113537124.586.790.253212949751.05940438CS
52-8.208-96.79245283028.489.980.25325057611.58598963CS
156-20.728-98.704761904821220.25323798272.49411821CS
2600000.3079000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
205.22k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
50.1M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.87M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.91M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.21M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
29.83M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
30.61M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
4.79M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
238.43M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
183.73M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
136.36M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
127.78M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
120.81M

LYRA Discussion

View Posts
Dennis14 Dennis14 1 month ago
Earnings out.
👍️0
Dennis14 Dennis14 1 month ago
Big buys after hours 86000 buy and (3)50000 buys
👍️0
Dennis14 Dennis14 1 month ago
It now says 13th after hours. We will see
👍️0
Dennis14 Dennis14 1 month ago
Earnings supposed to be on the 12th Aug.
👍️0
Dennis14 Dennis14 2 months ago
I just read. Earnings coming out next week or the week after.
👍️0
Dennis14 Dennis14 2 months ago
Earnings coming out any day now.
👍️0
BigBadWolf BigBadWolf 3 months ago
DDAmanda finds them early so that Han's (he provided the name pumping testimonials) can sell off his early buys while he's pumping to his paid subscribers. Want proof DDAmanda $subscribers PM me for verification or simply check my posting history for the mud this P_G waddles in..
https://lyratherapeutics.com/
👍️0
Zardiw Zardiw 3 months ago
Well, 6 weeks ago she was $5: $LYRA Chart from #DDAmanda - #1 Stock Screener :

Find Winners Early:



Z
👍️0
Termite7 Termite7 3 months ago
Who? .....How high for LYRA? .......Thanks!!!
👍️0
Zardiw Zardiw 3 months ago
Nice list.........$LYRA is due.......according to #DDAmanda.

Z
👍️0
Termite7 Termite7 3 months ago
Oversold!!! ......https://finviz.com/screener.ashx?v=110&s=ta_oversold&o=change
👍️0
Zardiw Zardiw 4 months ago
$LYRA Book Value is $1.27 ......trading at .34 ........or 1/4 the BV........

Z
👍️ 1
INV4 INV4 4 months ago
LYRA Institutional Holdings
Ownership Summary

Institutional Ownership • 74.73%
Total Shares Outstanding (millions) • 61
Total Value of Holdings (millions) • $16

Active Positions • Holders • Shares
Increased Positions • 54 • 9,224,767
Decreased Positions • 19 • 6,026,566
Held Positions • 11 • 30,304,888

Institutional Holders: 84
Total Shares Held: 45,556,221

$BLEG

LYRA Analyst Research
Lyra Therapeutics, Inc. Common Stock (LYRA) Analyst Research
LYRA Earnings Consensus

CONSENSUS
Buy
Based on 6 analysts offering recommendations for 'LYRA'.

Analyst Price Targets
CONSENSUS
$0.95

Based on analysts offering 12 month price targets for LYRA in the last 3 months.
The average price target is $0.95 with a high estimate of $2 and a low estimate of $0.35.

https://www.nasdaq.com/market-activity/stocks/lyra/analyst-research

$LYRA
👍️0
Zardiw Zardiw 4 months ago
$LYRA Bounce anytime now...............

Z
👍️ 1
INV4 INV4 4 months ago
Let's see when it bounces 😀

$LYRA
👍️0
glenn1919 glenn1919 4 months ago
LYRA.........................................https://stockcharts.com/h-sc/ui?s=LYRA&p=W&b=5&g=0&id=p86431144783
👍️0
Zardiw Zardiw 4 months ago
Yes. Expecting a nice $LYRA Bounce..............

Z
👍️0
Dennis14 Dennis14 4 months ago
Relative Strength Index is at 12 this is way over sold.
👍️0
Zardiw Zardiw 4 months ago
$LYRA Book Value: $1.28 ....currently at .43 ...

Z
👍️0
Dennis14 Dennis14 4 months ago
Bought in this morning at .42, I believe this will be back to at least 1 or 2 bucks.
👍️0
axelvento axelvento 4 months ago
game over: announced topline results from the Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS). ENLIGHTEN 1 did not meet its primary endpoint
👍️0
Monksdream Monksdream 5 months ago
LYRA under $10

👍️0
Monksdream Monksdream 6 months ago
LYRA under $10
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...NOT HOLDING INTO ER
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...LETS SEE 7.00
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...EXPLODING!!!!!
👍️0
Monksdream Monksdream 6 months ago
LYRA 10Q due March 14
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...BEAUTIFUL BREAK OUT
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA....BIO BEAST!
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...MOVES ON AIR!!!
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...HERE WE GO
👍️0
Monksdream Monksdream 6 months ago
LYRA 10Q due March 7
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA..WHAT A BEAUTY...NOBODY TALKING!!!
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
LYRA...NEXT BIO BEAST READY TO BEAST
👍️0
Monksdream Monksdream 1 year ago
LYRA No 3 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

Delayed Upgrade Clock